Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-04

Clinical Trial Update: NEIVATECH Virtual Reality-based System for Amblyopia [NA]

View source ↗

Summary

A clinical trial evaluating the NEIVATECH VR-based system for amblyopia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEIVATECH Virtual Reality-based System

Snippet

Sponsor: Increase-Tech | Conditions: Amblyopia | NA | Status: TERMINATED